| Phased versus midventilation attenuation-corrected respiration-correlated PET for patients with non-small cell lung cancer. | |
| | |
MedLine Citation:
|
PMID: 19914979 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
Respiration-correlated PET (RCPET) can reduce motion artifacts, but image quality generally decreases. The use of phase-by-phase attenuation correction (PAC) for RCPET using respiration-correlated CT (RCCT) requires large computational resources, and tumor positions will not always match correctly because of different binning methods for CT and PET. In this study, we investigated whether PAC for RCPET can be replaced by midventilation attenuation correction (MidV-AC) for a group of lung cancer patients. METHODS: RCPET/CT scans of 19 non-small cell lung cancer patients were performed. List-mode PET and CT data were binned and reconstructed into 8 phases. Two AC methods for RCPET were applied. First, the corresponding 8 RCCT phases were used for PAC. Then MidV-AC was used. Analyses were performed in terms of standardized uptake values (SUVs), volume recovery, contrast, and signal-to-noise ratio (SNR). RESULTS: Average differences between PAC and MidV-AC for mean and maximum SUV were 1.0% and 0.9% (P = 0.007 and P = 0.002), respectively, whereas SNR, contrast, and volume did not differ significantly (P >or= 0.2). Large motion amplitudes and irregular breathing revealed larger differences between phase 1 and MidV-AC values. CONCLUSION: Differences in SUV, volume, SNR, and contrast between PAC as available in currently used clinical software and MidV-AC for RCPET are small. MidV-AC provides an excellent surrogate for PAC for most lung cancer patients encountered in clinical practice. |
| | |
Authors:
|
Tezontl Rosario; Michel C Ollers; Geert Bosmans; Dirk De Ruysscher; Philippe Lambin; Andre Dekker |
Related Documents
:
|
11918659 - Neuroinflammation of the nigrostriatal pathway during progressive 6-ohda dopamine degen... 17821979 - Performance comparison of two commercial bgo-based pet/ct scanners using nema nu 2-2001. 8315489 - A gallium-68 radiopharmaceutical that is retained in myocardium: 68ga[(4,6-meo2sal)2bap... 7839959 - Noninvasive assessment of myocardial perfusion and metabolism: feasibility of registeri... 16911459 - Value of fusing pet plus ct images in hepatocellular carcinoma and combined hepatocellu... 19646559 - Multimodality imaging: beyond pet/ct and spect/ct. 21095839 - Intelligent clinical decision support systems based on snomed ct. 16555629 - Hepatic adenomatous hyperplasia with hyperattenuation on ct during arterial portography... 12514629 - Is there a role for intravenous transpulmonary contrast imaging in pediatric stress ech... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2009-11-13 |
Journal Detail:
|
Title: Journal of nuclear medicine technology Volume: 37 ISSN: 1535-5675 ISO Abbreviation: J Nucl Med Technol Publication Date: 2009 Dec |
Date Detail:
|
Created Date: 2009-12-01 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0430303 Medline TA: J Nucl Med Technol Country: United States |
Other Details:
|
Languages: eng Pagination: 208-14 Citation Subset: IM |
Affiliation:
|
Department of Radiotherapy Physics, Catharina Hospital, Eindhoven, The Netherlands. tezontl.rosario@cze.nl |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: PET/CT-Guided Percutaneous Biopsy of Isolated Intramuscular Metastases from Postcricoid Cancer.
Next Document: Semiqualitative Visual and Quantitative Morphometric Evaluations of Reduced Scan Time and Wide-Beam ...